2. Neuronal Signaling NF-κB Apoptosis
  3. Monoamine Oxidase RANKL/RANK TNF Receptor NF-κB IKK
  4. 2'-Acetylacteoside

2'-Acetylacteoside (2'-AA) is a natural compound with oral activity and blood-brain barrier permeability. 2'-Acetylacteosideexhibits MAO‑B inhibitory activity (IC50 = 17.71 μM, Ki = 13.81 μM). 2'-Acetylacteoside downregulates the expression of RANK, TRAF6, NF‑κB, NFATc1 and IKKβ, disrupts the RANKL/RANK interaction, blocks downstream signaling pathways, and increases the level of phosphorylated Akt. 2'-Acetylacteoside possesses potent anti-osteoclastogenic, anti-bone resorptive, pro-neurogenic, neuroprotective and antioxidant activities. 2'-Acetylacteoside can be used in the research of osteoporosis, ischemic stroke and Parkinson's disease.

For research use only. We do not sell to patients.

2'-Acetylacteoside

2'-Acetylacteoside Chemical Structure

CAS No. : 94492-24-7

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
5 mg In-stock
10 mg In-stock
20 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of 2'-Acetylacteoside:

2'-Acetylacteoside Related Antibodies

Top Publications Citing Use of Products

1 Publications Citing Use of MCE 2'-Acetylacteoside

View All Monoamine Oxidase Isoform Specific Products:

View All Isoforms
MAO-A MAO-B

View All TNF Receptor Isoform Specific Products:

View All Isoforms
TNFRSF1A/CD120a TNFRSF3/CD18 TNFRSF4 TNFRSF5/CD40 TNFRSF6/Fas/CD95 TNFRSF7/CD27 TNFRSF8/CD30 TNFRSF9/4-1BB/CD137 TNFRSF10B/DR5/CD262 TNFRSF12A/TWEAK TNFRSF16/NGF Receptor/CD271 TNFRSF18/GITR/CD357

View All NF-κB Isoform Specific Products:

View All Isoforms
NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

View All IKK Isoform Specific Products:

View All Isoforms
IKK-α IKK-β IKK IKKε TBK1

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

2'-Acetylacteoside (2'-AA) is a natural compound with oral activity and blood-brain barrier permeability. 2'-Acetylacteosideexhibits MAO‑B inhibitory activity (IC50 = 17.71 μM, Ki = 13.81 μM). 2'-Acetylacteoside downregulates the expression of RANK, TRAF6, NF‑κB, NFATc1 and IKKβ, disrupts the RANKL/RANK interaction, blocks downstream signaling pathways, and increases the level of phosphorylated Akt. 2'-Acetylacteoside possesses potent anti-osteoclastogenic, anti-bone resorptive, pro-neurogenic, neuroprotective and antioxidant activities. 2'-Acetylacteoside can be used in the research of osteoporosis, ischemic stroke and Parkinson's disease[1][2][3][4].

IC50 & Target[2]

MAO-B

 

NF-κB

 

IKKβ

 

In Vitro

2'-Acetylacteoside (10-7-10-5 mol/L; 0.5 h, 24 h, 6 days) inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells and down-regulates the expression of key proteins in the RANKL/RANK/TRAF6-mediated NF-κB/NFATc1 pathway[1].
2'-Acetylacteoside binds to Akt3 protein in cultured adult SVZ-derived NSCs, protecting it from protease degradation[2].
2'-Acetylacteoside (5-40 μM; 24 h) promotes proliferation of OGD/R-treated adult SVZ-derived NSCs[2].
2'-Acetylacteoside (10 μM; 24 h) enhances the proliferation of OGD/R-treated adult SVZ-derived NSCs in vitro, as shown by a significant increase in EdU-positive cells[2].
2'-Acetylacteoside (10 μM) promotes differentiation of OGD/R-treated adult SVZ-derived NSCs into immature neurons (DCX-positive) in vitro, without affecting gliogenesis[2].
2'-Acetylacteoside (10 μM) promotes proliferation and neurogenesis of OGD/R-treated adult SVZ-derived NSCs in vitro via activation of the PI3K/Akt pathway, as shown by increased p-Akt, p-CREB, DCX, and NeuN expression[2].
2'-Acetylacteoside alters gene expression in OGD/R-treated adult SVZ-derived NSCs in vitro, with significant enrichment of differentially expressed genes in the PI3K/Akt signaling pathway, and up-regulates neurogenesis-related genes including VEGFα, Errb4, Col1a1, and Igfbp5[2].
2'-Acetylacteoside potently inhibited purified MAO-B enzyme in vitro with an IC₅₀ of 17.71 μM and acted as a reversible mixed inhibitor with high affinity for free MAO-B (Ki = 13.81 μM)[3].
2'-Acetylacteoside (25-100 μM) scavenges superoxide radicals in a concentration-dependent manner in a cell-free in vitro system[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

2'-Acetylacteoside Related Antibodies

Cell Proliferation Assay[2]

Cell Line: cultured adult subventricular zone (SVZ)-derived neural stem cells (NSCs) under oxygen-glucose deprivation/reoxygenation (OGD/R) conditions
Concentration: 5, 10, 20, 40 μM (post-OGD/R incubation); 10 μM (optimal, 24 h incubation)
Incubation Time: 24 h (optimal concentration incubation); 2 h (CCK-8 solution incubation)
Result: Increased NSC viability significantly at all tested concentrations, with 10 μM showing the most potent effect on proliferation.
Reached the highest proliferation rate 24 h post-treatment.

Cell Proliferation Assay[2]

Cell Line: cultured adult subventricular zone (SVZ)-derived neural stem cells (NSCs) under oxygen-glucose deprivation/reoxygenation (OGD/R) conditions
Concentration: 10 μM (post-OGD/R incubation); 50 μM (EdU medium)
Incubation Time: 24 h (post-OGD/R incubation); 2 h (EdU medium incubation)
Result: Increased the number of EdU-positive cells significantly compared to the OGD/R-only group, with approximately 30% of control cells being EdU-positive and OGD/R treatment already increasing proliferative capacity.

Western Blot Analysis[2]

Cell Line: Mouse neural stem cells (NSCs)
Concentration: 10 μM
Incubation Time: 24 h
Result: Upregulated the expression of p-Akt, p-CREB, DCX, and NeuN.
In Vivo

2'-Acetylacteoside (2'-AA) (10-40 mg/kg/day; p.o.; daily; 12 weeks) exhibits significant anti-osteoporotic activity in ovariectomized mice, all doses improving trabecular bone microarchitecture and biomechanical strength via inhibition of the RANKL/RANK/TRAF6-mediated NF-κB/NFATc1 pathway[1].
2'-Acetylacteoside (2'-AA) (total glycosides of Cistanche deserticola, p.o.) was detected in brain tissue, and specifically binds to the central target MAO‑B in the brain as determined by UPLC-Q-Exactive-Orbitrap MS[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Kunming (female, 8-week-old, 26 g, osteoporosis induced by bilateral ovariectomy)[1]
Dosage: 10 mg/kg/day; 20 mg/kg/day; 40 mg/kg/day
Administration: p.o.; daily; 12 weeks
Result: Left body, uterus, and vagina weights unchanged in OVX mice.Enhanced femoral mechanical properties, trabecular BMD, BMC, TMC, BVF, Tb.Th, and Tb.N.Reduced trabecular separation across all doses.
Inhibited serum TRAP, cathepsin K, and DPD activities at 40 mg/kg/day.
Diminished bone resorption markers significantly at lower doses.
Showed no significant effect on bone formation markers (ALP, BGP).
Downregulated RANK, TRAF6, IKKβ, NF‑κB, and NFATc1 expression, blocking the RANKL/RANK/TRAF6‑mediated NF‑κB/NFATc1 pathway.
Molecular Weight

666.62

Formula

C31H38O16
CAS No.
Appearance

Solid

Color

Off-white to light yellow

SMILES

OC1=CC=C(/C=C/C(O[C@H]2[C@H](O[C@]3([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](OC(C)=O)[C@H](OCCC4=CC=C(O)C(O)=C4)O[C@@H]2CO)=O)C=C1O
Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

-20°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

Solvent & Solubility
In Vitro: 

DMSO : 100 mg/mL (150.01 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Ethanol : ≥ 100 mg/mL (150.01 mM)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.5001 mL 7.5005 mL 15.0010 mL
5 mM 0.3000 mL 1.5001 mL 3.0002 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (3.75 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (3.75 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
% 
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.73%

SDS (396 KB)

COA (254 KB) HNMR (289 KB) LCMS (95 KB)

Handling Instructions (2659 KB)
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO / Ethanol 1 mM 1.5001 mL 7.5005 mL 15.0011 mL 37.5026 mL
5 mM 0.3000 mL 1.5001 mL 3.0002 mL 7.5005 mL
10 mM 0.1500 mL 0.7501 mL 1.5001 mL 3.7503 mL
15 mM 0.1000 mL 0.5000 mL 1.0001 mL 2.5002 mL
20 mM 0.0750 mL 0.3750 mL 0.7501 mL 1.8751 mL
25 mM 0.0600 mL 0.3000 mL 0.6000 mL 1.5001 mL
30 mM 0.0500 mL 0.2500 mL 0.5000 mL 1.2501 mL
40 mM 0.0375 mL 0.1875 mL 0.3750 mL 0.9376 mL
50 mM 0.0300 mL 0.1500 mL 0.3000 mL 0.7501 mL
60 mM 0.0250 mL 0.1250 mL 0.2500 mL 0.6250 mL
80 mM 0.0188 mL 0.0938 mL 0.1875 mL 0.4688 mL
100 mM 0.0150 mL 0.0750 mL 0.1500 mL 0.3750 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

2'-Acetylacteoside Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

2'-Acetylacteoside94492-24-72'-AAMonoamine OxidaseRANKL/RANKTNF ReceptorNF-κBIKKMAOTumor Necrosis Factor ReceptorTNFRNuclear factor-κBNuclear factor-kappaBIκB kinaseI kappa B kinaseMAO-BTRAF6RANKRAW264.7 cellsNFATc1SVZ-derived NSCsIKKβovariectomized miceAkt3Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
2'-Acetylacteoside
Cat. No.:
HY-N0026
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (396 KB) Français - FR (396 KB) Deutsch - DE (396 KB) Norwegian - NO (396 KB) Español - ES (396 KB) Swedish - SV (396 KB) Italian - IT (396 KB) Korean - KR (396 KB) Portuguese - PT (396 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.